Consider you are warned - werkgeversreview Clinical Study Manager bij BeOne

1,0
12 nov 2021
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Pay higher than most US pharma to attract experienced folks and will attempt to keep you using attractive RSUs with long vesting schedule

Minpunten

Majority of the negative comments here are true. The company is controlled and directed essentially by leadership team from China who does not follow or respect FDA guidance very well and often make critical mistakes. Lack of standards process, extremely high turnover and always hiring like crazy. Expect you to work late hours to cope with time zone difference and pressure from senior management. US based directors and ADs don’t have real control and are panic driven by Chinese leadership. They survive on asking middle management to shoulder all responsibilities for them and feed them with new ideas and strategies to present.

Ontdek andere reviews over BeOne

5,0
24 apr 2026
Anonieme werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Minpunten

Fast timelines and global expansion may translate into heavy workload and urgency

1,0
21 mei 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Some great people and opportunities to truly learn the CN market

Minpunten

Toxic culture, lack of coherent leadership strategies, unreasonable expectations

1
Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle